What is driving M&A activity in the MedTech space?
By GlobalData
The COVID-19 pandemic has left an indelible mark on the MedTech landscape. Changes in how healthcare is delivered, and new treatment modalities, are creating opportunities and challenges for both new and traditional players.
As companies sought out opportunities during the pandemic-driven downturn, the number and value of mergers and acquisition deals in the MedTech space increased. Companies worked to reposition themselves in the newly aligned healthcare world, but with further economic turmoil expected: will these trends be repeated? And what tech areas should firms be looking to expand their capabilities into?
GlobalData’s report, “Themes driving M&A activity in the Medical Devices Sector, Q1 2022,” draws upon GlobalData’s extensive MedTech deals databases, highlighting major trends and hot themes in M&A activity.
This report will assist you in:
- Understanding value and volume trends in M&A from Q1 2018 to Q1 2022
- Understanding regional trends in M&A activity
- Understanding which medical device sectors are leading M&A activity, and which are lagging
- Understanding the leading tech trends in Q1 2022 M&A activity
- Knowing the key deals that occurred during Q1 2022